Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025EMJ HematologyOpen Access

Recent Developments in Chronic Lymphocytic Leukaemia Research: Interview with an Expert

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBart Lee ScottUniversity of Washington

Discussion

Loading...

Member takes

Implication

Expert interview discusses advances in chronic lymphocytic leukaemia treatments and highlights targeted therapies.

Key Points

  • Management of chronic lymphocytic leukaemia remains challenging despite effective targeted therapies.
  • Key therapies include bruton tyrosine kinase inhibitors like acalabrutinib and venetoclax.
  • Emerging therapies like pirtobrutinib and epcoritamab provide new options for patients with CLL.
  • Future developments may focus on individualized therapy tailored to patients' specific needs.

Cite This Study

Bart L. Scott (2025) studied this question.

synapsesocial.com/papers/68c23e94b210217d64792f6bhttps://doi.org/10.33590/emjhematol/iqcc8658
View Full Paper
Ask AI
Bookmark
Share